← Leaderboards
Christopher Tuggle
Iowa State University
$6,651,588
Attributed
$6,651,588
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $987.7K · FY2015–25$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,651,588 · 2
By mechanism
R24$6,651,588 · 2
Top collaborators
No co-investigators on record.
Most similar at Iowa State University
Same institution · by research overlap
- Edward W Yu$11,743,923
- Robbyn Kimberly Anand$556,484
- Lin Zhou$1,114,933
- Robert Horton$985,512
- Costas M Soukoulis$249,015
Others in their field
Top investigators on “Xenograft Procedure”
- David Heimbrook · Leidos Biomedical Research, Inc.$97,763,818
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,381,339
- Leonard Freedmand · Leidos Biomedical Research, Inc.$52,916,621
- Peter J Houghton · University Of Texas Hlth Science Center$20,565,889
- Connie Suders · Leidos Biomedical Research, Inc.$19,812,417
- David H Sachs · Columbia University Health Sciences$18,932,200
Research focus
Xenograft ProcedureHuman BiologyProtocols DocumentationTranslationsInterestGenerationsImmunePre-Clinical ModelStem CellsStem Cell TherapyFamily SuidaeAnimalsAnimal ModelArtemisClinicBiocontainment FacilityPre-ClinicalCellsMutantRegenerative MedicineEngraftmentImmune SystemGenetic ResourceBone Marrow
Grant awards (11)
Developing second generation SCID pig models: filling the gaps to improve translation of therapeutics in regenerative medicine$763,121
R24 · FY2025 · OD · contact PI
Developing second generation SCID pig models: filling the gaps to improve translation of therapeutics in regenerative medicine$730,384
R24 · FY2023 · OD · contact PI
Developing second generation SCID pig models: filling the gaps to improve translation of therapeutics in regenerative medicine$738,090
R24 · FY2022 · OD · contact PI
Developing second generation SCID pig models: filling the gaps to improve translation of therapeutics in regenerative medicine$742,315
R24 · FY2021 · OD · contact PI
Developing second generation SCID pig models: filling the gaps to improve translation of therapeutics in regenerative medicine$245,428
R24 · FY2021 · OD · contact PI
Developing second generation SCID pig models: filling the gaps to improve translation of therapeutics in regenerative medicine$740,894
R24 · FY2020 · OD · contact PI
Expanding the Utility of Severe Combined Immuno-Deficient (SCID) Pig Models$160,959
R24 · FY2019 · OD · contact PI
Expanding the Utility of Severe Combined Immuno-Deficient (SCID) Pig Models$606,407
R24 · FY2018 · OD · contact PI
Expanding the Utility of Severe Combined Immuno-Deficient (SCID) Pig Models$608,822
R24 · FY2017 · OD · contact PI
Expanding the Utility of Severe Combined Immuno-Deficient (SCID) Pig Models$658,842
R24 · FY2016 · OD · contact PI
Expanding the Utility of Severe Combined Immuno-Deficient (SCID) Pig Models$656,326
R24 · FY2015 · OD · contact PI